Investigation of Oxidative Stress Markers in Essential Hypertension

被引:8
|
作者
Toker, Aysun [1 ]
Mehmetoglu, Idris [1 ]
Yerlikaya, F. Humeyra [1 ]
Nergiz, Suleyman [2 ]
Kurban, Sevil [1 ]
Gok, Hasan [3 ]
机构
[1] Necmettin Erbakan Univ, Meram Med Fac, Dept Biochem, Meram Konya, Turkey
[2] Selcuk Univ, Sekuklu Med Fac, Dept Genet, Selcuklu Konya, Turkey
[3] Necmettin Erbakan Univ, Meram Med Fac, Dept Cardiol, Meram Konya, Turkey
关键词
essential hypertension; total antioxidant status; total oxidant status; ischemia modified albumin; ISCHEMIA-MODIFIED ALBUMIN; TOTAL ANTIOXIDANT STATUS; ESSENTIAL ARTERIAL-HYPERTENSION; LIPID-PEROXIDATION; NITRIC-OXIDE; DNA-DAMAGE; INFLAMMATION; ASSOCIATION; BIOMARKERS;
D O I
10.7754/Clin.Lab.2012.120128
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The main goal of this study was to evaluate ischemia modified albumin (IMA), total antioxidant status (TAS), and total oxidant status (TOS) levels in treated essential hypertensive patients and to compare them with levels of normotensive subjects. Methods: In 45 hypertensive and 30 control subjects, serum levels of IMA were determined manually using a spectrophotometric Co(II)-albumin binding assay. TAS and TOS levels were evaluated spectrophotometrically. Lipid profile was estimated by routine methods. Results: Hypertensive patients had significantly higher levels of TOS and IMA (p = 0.020 and p = 0.034, respectively) and lower levels of TAS (p = 0.016) in comparison with control subjects. Serum levels of TAS were negatively correlated with TOS and IMA levels in the patient group. Serum levels of TOS were also positively correlated with IMA levels. There was no significant correlation between blood pressure and TAS, TOS, and IMA levels. Conclusions: Our results showed higher levels of IMA in hypertensive patients. We suggest that higher levels of IMA may result from increased oxidative stress and decreased antioxidant status in hypertensive patients.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 50 条
  • [21] Implications of oxidative stress and homocysteine in the pathophysiology of essential hypertension
    Rodrigo, R
    Passalacqua, W
    Araya, J
    Orellana, M
    Rivera, G
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 42 (04) : 453 - 461
  • [22] Essential Hypertension and Oxidative Stress: Novel Future Perspectives
    Franco, Caterina
    Sciatti, Edoardo
    Favero, Gaia
    Bonomini, Francesca
    Vizzardi, Enrico
    Rezzani, Rita
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [23] Oxidative stress and left ventricular remodeling in essential hypertension
    Giner, V
    Rodilla, E
    Tormos, M
    Espinosa, O
    Jimenez, J
    Chaves, F
    Pascual, J
    Saez, G
    Redon, J
    JOURNAL OF HYPERTENSION, 2005, 23 : S194 - S194
  • [24] Increased markers of oxidative stress in salt sensitive hypertension
    Larrousse, M
    Bragulat, E
    Deulofeu, R
    Sierra, C
    Coca, A
    De la Sierra, A
    JOURNAL OF HYPERTENSION, 2003, 21 : S189 - S189
  • [25] Markers of oxidative stress in obese men with and without hypertension
    Cejvanovic, Vanja
    Asferg, Camilla
    Kjaer, Laura Kofoed
    Andersen, Ulrik B.
    Linneberg, Allan
    Frystyk, Jan
    Henriksen, Trine
    Flyvbjerg, Allan
    Christiansen, Michael
    Weimann, Allan
    Jeppesen, Jorgen
    Poulsen, Henrik Enghusen
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2016, 76 (08): : 620 - 625
  • [26] Oxidative stress: does it play a role in the genesis of essential hypertension and hypertension of uraemia?
    Tepel, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (08) : 1439 - 1442
  • [27] Chronic mental stress is a cause of essential hypertension: Presence of biological markers of stress
    Esler, Murray
    Eikelis, Nina
    Schlaich, Markus
    Lambert, Gavin
    Alvarenga, Marlies
    Dawood, Tye
    Kaye, David
    Barton, David
    Pier, Ciaran
    Guo, Ling
    Brenchley, Celia
    Jennings, Garry
    Lambert, Elisabeth
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2008, 35 (04) : 498 - 502
  • [28] Oxidative stress and left ventricular mass and shape in essential hypertension
    Giner, V
    Rodilla, E
    Tormos, MC
    Espinosa, O
    Jimenez, J
    Chaves, FJ
    Pascual, JM
    Saez, G
    Redon, J
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 122A - 122A
  • [29] Candesartan reduces oxidative stress and inflammation in patients with essential hypertension
    Dohi, Y
    Ohashi, M
    Sugiyama, M
    Takase, H
    Sato, K
    Ueda, R
    HYPERTENSION RESEARCH, 2003, 26 (09) : 691 - 697
  • [30] Nitric oxide metabolites and oxidative stress in mild essential hypertension
    Caimi, G.
    Mule, G.
    Hopps, E.
    Carollo, C.
    Lo Presti, R.
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2010, 46 (04) : 321 - 325